<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00450268</url>
  </required_header>
  <id_info>
    <org_study_id>EK208122001</org_study_id>
    <nct_id>NCT00450268</nct_id>
  </id_info>
  <brief_title>Dendritic Cells in Patients Following Allogeneic Hematopoietic Stem Cell Transplantation</brief_title>
  <acronym>DCalloTX</acronym>
  <official_title>Analysis of Dendritic Cells in Patients Following Allogeneic Hematopoietic Stem Cell Transplantation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Technische Universität Dresden</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Technische Universität Dresden</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      We plan to investigate prospectively and simultaneously skin and blood DC subtypes, their&#xD;
      donor/recipient origin and the correlation of DC reconstitution kinetics with treatment,&#xD;
      clinical outcome and incidence of aGvHD in patients undergoing allogeneic hematopoietic stem&#xD;
      cell transplantation.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Blood and skin DC reconstitution shall be investigated in patients affected by hematological&#xD;
      diseases and receiving HLA-matched, mobilized peripheral blood stem cells from related or&#xD;
      unrelated donors. We plan to simultaneously collect and process double biopsies, i.e. from&#xD;
      graft versus host disease affected and non-lesional skin of patients at onset of acute graft&#xD;
      versus host disease following allogeneic hematopoietic stem cell transplantation. Emigration&#xD;
      assay, Chimerism analysis and immunohistochemistry will be performed.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 2005</start_date>
  <completion_date type="Anticipated">January 2010</completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Defined Population</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <enrollment>50</enrollment>
  <condition>Graft Versus Host Disease</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>blood draw, skin shave biopsy</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient undergoing an allogeneic hematopoietic stem cell transplantation&#xD;
&#xD;
          -  Older than 18 years&#xD;
&#xD;
          -  WHO-Performance-Status 0 to3&#xD;
&#xD;
          -  Informed consent&#xD;
&#xD;
          -  Graft versus host disease of the skin&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Clotting parameters more than double of normal&#xD;
&#xD;
          -  Infection of the skin&#xD;
&#xD;
          -  Leucocytes &lt; 1000/µl; Thrombocytes &lt; 20 000/µl&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Susanne Gretzinger, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universität Carl Gustav Carus Med Klinik I</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Susanne Gretzinger, MD</last_name>
    <phone>+49 351 458</phone>
    <phone_ext>2583</phone_ext>
    <email>susanne.gretzinger@uniklinik-dresden.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Martin Bornhäuser, Professor</last_name>
    <phone>*49 351 458</phone>
    <phone_ext>4190</phone_ext>
    <email>martin.bormhaeuser@uniklinik-dresden.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Universitätsklinik Carl Gustav Carus</name>
      <address>
        <city>Dresden</city>
        <zip>01307</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Susanne Gretzinger, MD</last_name>
      <phone>+49 351 458</phone>
      <phone_ext>2583</phone_ext>
      <email>susanne.gretzinger@uniklinik-dresden.de</email>
    </contact>
    <contact_backup>
      <last_name>Martin Bornhaeuser, MD</last_name>
      <phone>+49 351 458</phone>
      <phone_ext>4190</phone_ext>
      <email>Martin.Bornhaeuser@uniklinik-dresden.de</email>
    </contact_backup>
    <investigator>
      <last_name>Susanne Gretzinger, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Martin Bornhaeuser, Prof</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Christian Thiede, Prof</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>March 2007</verification_date>
  <study_first_submitted>March 21, 2007</study_first_submitted>
  <study_first_submitted_qc>March 21, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 22, 2007</study_first_posted>
  <last_update_submitted>March 21, 2007</last_update_submitted>
  <last_update_submitted_qc>March 21, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 22, 2007</last_update_posted>
  <keyword>Graft versus host disease</keyword>
  <keyword>Allogeneic hematpoietic stem cell transplantation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Graft vs Host Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

